Literature DB >> 24334519

Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important?

Domokos Bartis1, Nikica Mise2, Rahul Y Mahida1, Oliver Eickelberg2, David R Thickett1.   

Abstract

Epithelial-mesenchymal transition (EMT) is a process when epithelial cells gradually transform into mesenchymal-like cells losing their epithelial functionality and characteristics. EMT is thought to be involved in the pathogenesis of numerous lung diseases ranging from developmental disorders, fibrotic tissue remodelling to lung cancer. The most important question--namely what is the importance and contribution of EMT in the pathogenesis of several chronic lung conditions (asthma, COPD, bronchiolitis obliterans syndrome and lung fibrosis)--is currently intensely debated. This review gives a brief insight into the mechanism and assessment methods of EMT in various pulmonary diseases and summarises the recent literature highlighting the controversial experimental data and conclusions. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24334519     DOI: 10.1136/thoraxjnl-2013-204608

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  107 in total

1.  Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.

Authors:  Malik Quasir Mahmood; Chris Ward; Hans Konrad Muller; Sukhwinder Singh Sohal; Eugene Haydn Walters
Journal:  Med Oncol       Date:  2017-02-14       Impact factor: 3.064

Review 2.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

3.  Adapted approach to profile genes while reconciling Vegf-a mRNA expression in the developing and injured lung.

Authors:  Daniel D Lee; Margaret A Schwarz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-10       Impact factor: 5.464

4.  Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.

Authors:  Hibiki Udagawa; Genichiro Ishii; Masahiro Morise; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Hironobu Ohmatsu; Masahiro Tsuboi; Koichi Goto; Atsushi Ochiai; Yuichiro Ohe
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-09       Impact factor: 4.553

5.  2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

Authors:  Dayong Zheng; Xing Chang; Yang Liu; Jingwen Xu; Wenfeng Gou; Zengqiang Li; Daiying Zuo; Weige Zhang; Yingliang Wu
Journal:  Cancer Biol Ther       Date:  2018-12-04       Impact factor: 4.742

6.  Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotype.

Authors:  Naoya Fujino; Hiroshi Kubo; Rose A Maciewicz
Journal:  Lab Invest       Date:  2017-05-29       Impact factor: 5.662

7.  MicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1.

Authors:  Jingbin Ni; Yisha Yang; Di Liu; Hui Sun; Shimao Jin; Jingying Li
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

8.  Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-β1 induced epithelial-mesenchymal transition.

Authors:  Xinrui Tian; Xinli Tian; Rujie Huo; Qin Chang; Guoping Zheng; Yan Du; Yan Chen; Bo Niu
Journal:  Hum Vaccin Immunother       Date:  2017-04-25       Impact factor: 3.452

9.  Cigarette smoke extract induces the epithelial-to-mesenchymal transition via the PLTP/TGF-β1/Smad2 pathway in RLE-6TN cells.

Authors:  Hong Chen; Feng-Ping Wu; Yong-Zhen Yang; Xiu-Ying Yu; Lu Zhang; Hui Zhang; Ya-Juan Chen
Journal:  Toxicol Res (Camb)       Date:  2016-12-23       Impact factor: 3.524

10.  Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.

Authors:  Deyao Wu; Xiaobing Niu; Huixing Pan; Yunfeng Zhou; Zichun Zhang; Ping Qu; Jian Zhou
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.